Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 553

1.

Cellular Mucins: Targets for Immunotherapy.

Apostolopoulos V, McKenzie IFC.

Crit Rev Immunol. 2017;37(2-6):421-437. doi: 10.1615/CritRevImmunol.v37.i2-6.110. Review.

PMID:
29773028
2.

MUC1 immunotherapy against a metastatic mammary adenocarcinoma model: Importance of IFN-gamma.

Lees CJ, Smorodinsky N, Horn G, Wreschner DH, McKenzie IF, Pietersz G, Stojanovska L, Apostolopoulos V.

Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2016;37(1):15-25. doi: 10.1515/prilozi-2016-0001.

PMID:
27442413
3.

Dendritic cell immunotherapy: clinical outcomes.

Apostolopoulos V, Pietersz GA, Tsibanis A, Tsikkinis A, Stojanovska L, McKenzie IF, Vassilaros S.

Clin Transl Immunology. 2014 Jul 18;3(7):e21. doi: 10.1038/cti.2014.14. eCollection 2014 Jul. Review.

4.

Tribute to Carl-Gustav Groth (1933-2014), first president of the International Xenotransplantation Association.

Cooper DK, Buhler L, Breimer M, Korsgren O, Tibell A, Wennberg L, Cozzi E, d'Apice AJ, Hering B, McKenzie IF, Pierson RN 3rd, Sykes M, Kobayashi T.

Xenotransplantation. 2014 Mar-Apr;21(2):97-8. doi: 10.1111/xen.12098. No abstract available.

PMID:
25268247
5.

A phase 2, single-arm study of an autologous dendritic cell treatment against mucin 1 in patients with advanced epithelial ovarian cancer.

Mitchell PL, Quinn MA, Grant PT, Allen DG, Jobling TW, White SC, Zhao A, Karanikas V, Vaughan H, Pietersz G, McKenzie IF, Gargosky SE, Loveland BE.

J Immunother Cancer. 2014 Jun 18;2:16. doi: 10.1186/2051-1426-2-16. eCollection 2014.

6.

Up to 15-year clinical follow-up of a pilot Phase III immunotherapy study in stage II breast cancer patients using oxidized mannan-MUC1.

Vassilaros S, Tsibanis A, Tsikkinis A, Pietersz GA, McKenzie IF, Apostolopoulos V.

Immunotherapy. 2013 Nov;5(11):1177-82. doi: 10.2217/imt.13.126.

PMID:
24188672
7.

Tobacco-related chronic illnesses: a public health concern for Jamaica.

Crawford TV, McGrowder DA, Barnett JD, McGaw BA, McKenzie IF, James LG.

Asian Pac J Cancer Prev. 2012;13(9):4733-8.

8.

Honorary Membership of International Xenotransplantation Association conferred upon Professor Ian F C McKenzie (September 18, 2007).

McKenzie IF.

Xenotransplantation. 2008 Sep-Oct;15(5):285-9. doi: 10.1111/j.1399-3089.2008.00491.x. No abstract available.

PMID:
19134145
9.

Carbohydrate residues downstream of the terminal Galalpha(1,3)Gal epitope modulate the specificity of xenoreactive antibodies.

Milland J, Yuriev E, Xing PX, McKenzie IF, Ramsland PA, Sandrin MS.

Immunol Cell Biol. 2007 Nov-Dec;85(8):623-32. Epub 2007 Aug 28.

PMID:
17724458
10.

Mannan-mediated gene delivery for cancer immunotherapy.

Tang CK, Lodding J, Minigo G, Pouniotis DS, Plebanski M, Scholzen A, McKenzie IF, Pietersz GA, Apostolopoulos V.

Immunology. 2007 Mar;120(3):325-35.

11.

Pilot phase III immunotherapy study in early-stage breast cancer patients using oxidized mannan-MUC1 [ISRCTN71711835].

Apostolopoulos V, Pietersz GA, Tsibanis A, Tsikkinis A, Drakaki H, Loveland BE, Piddlesden SJ, Plebanski M, Pouniotis DS, Alexis MN, McKenzie IF, Vassilaros S.

Breast Cancer Res. 2006;8(3):R27. Epub 2006 Jun 15.

12.

Delivery of tumor associated antigens to antigen presenting cells using penetratin induces potent immune responses.

Apostolopoulos V, Pouniotis DS, van Maanen PJ, Andriessen RW, Lodding J, Xing PX, McKenzie IF, Loveland BE, Pietersz GA.

Vaccine. 2006 Apr 12;24(16):3191-202. Epub 2006 Jan 25.

PMID:
16480791
13.

Mannan-MUC1-pulsed dendritic cell immunotherapy: a phase I trial in patients with adenocarcinoma.

Loveland BE, Zhao A, White S, Gan H, Hamilton K, Xing PX, Pietersz GA, Apostolopoulos V, Vaughan H, Karanikas V, Kyriakou P, McKenzie IF, Mitchell PL.

Clin Cancer Res. 2006 Feb 1;12(3 Pt 1):869-77.

14.

Pim-1 kinase stability is regulated by heat shock proteins and the ubiquitin-proteasome pathway.

Shay KP, Wang Z, Xing PX, McKenzie IF, Magnuson NS.

Mol Cancer Res. 2005 Mar;3(3):170-81.

15.

Size-dependent immunogenicity: therapeutic and protective properties of nano-vaccines against tumors.

Fifis T, Gamvrellis A, Crimeen-Irwin B, Pietersz GA, Li J, Mottram PL, McKenzie IF, Plebanski M.

J Immunol. 2004 Sep 1;173(5):3148-54.

16.

Cripto: a novel target for antibody-based cancer immunotherapy.

Xing PX, Hu XF, Pietersz GA, Hosick HL, McKenzie IF.

Cancer Res. 2004 Jun 1;64(11):4018-23.

17.

7th Congress of the International Xenotransplantation Association.

McKenzie IF.

Xenotransplantation. 2004 May;11(3):230-2. No abstract available.

PMID:
15099201
18.

Characterization of a CD46 transgenic pig and protection of transgenic kidneys against hyperacute rejection in non-immunosuppressed baboons.

Loveland BE, Milland J, Kyriakou P, Thorley BR, Christiansen D, Lanteri MB, Regensburg M, Duffield M, French AJ, Williams L, Baker L, Brandon MR, Xing PX, Kahn D, McKenzie IF.

Xenotransplantation. 2004 Mar;11(2):171-83.

PMID:
14962279
19.

CD46 protects pig islets from antibody but not cell-mediated destruction in the mouse.

McKenzie IF, Li YQ, Xing PX, Dinatale I, Koulmanda M, Loveland BE, Sandrin MS.

Xenotransplantation. 2003 Nov;10(6):615-21.

PMID:
14708531
20.

A glycopeptide in complex with MHC class I uses the GalNAc residue as an anchor.

Apostolopoulos V, Yuriev E, Ramsland PA, Halton J, Osinski C, Li W, Plebanski M, Paulsen H, McKenzie IF.

Proc Natl Acad Sci U S A. 2003 Dec 9;100(25):15029-34. Epub 2003 Dec 1.

22.

Aspects of cancer immunotherapy.

McKenzie IF, Apostolopoulos V, Plebanski M, Pietersz GA, Loveland BE.

Immunol Cell Biol. 2003 Feb;81(1):79-85.

PMID:
12534951
23.

Reduction of alpha-Gal expression by relocalizing alpha-galactosidase to the trans-Golgi network and cell surface.

Taylor SG, Osman N, McKenzie IF, Sandrin MS.

Glycobiology. 2002 Nov;12(11):729-39.

PMID:
12460941
24.

Use of the mannan receptor to selectively target vaccine antigens for processing and antigen presentation through the MHC class I and class II pathways.

Davis WC, Konzek RL, Haas K, Estes DM, Hamilton MJ, Call DR, Apostolopoulos V, McKenzie IF.

Ann N Y Acad Sci. 2002 Oct;969:119-25.

PMID:
12381575
25.

Pim-1 associates with protein complexes necessary for mitosis.

Bhattacharya N, Wang Z, Davitt C, McKenzie IF, Xing PX, Magnuson NS.

Chromosoma. 2002 Jul;111(2):80-95. Epub 2002 May 15.

PMID:
12111331
26.

Xenotransplantation trials.

McKenzie IF, d'Apice AJ, Cooper DK.

Lancet. 2002 Jun 29;359(9325):2280-1. No abstract available.

PMID:
12103325
27.

Crystal structure of a non-canonical high affinity peptide complexed with MHC class I: a novel use of alternative anchors.

Apostolopoulos V, Yu M, Corper AL, Li W, McKenzie IF, Teyton L, Wilson IA, Plebanski M.

J Mol Biol. 2002 May 17;318(5):1307-16. Erratum in: J Mol Biol 2002 Sep 13;322(2):478.

PMID:
12083519
28.

Crystal structure of a non-canonical low-affinity peptide complexed with MHC class I: a new approach for vaccine design.

Apostolopoulos V, Yu M, Corper AL, Teyton L, Pietersz GA, McKenzie IF, Wilson IA, Plebanski M.

J Mol Biol. 2002 May 17;318(5):1293-305. Erratum in: J Mol Biol 2002 Sep 13;322(2):477.

PMID:
12083518
29.

Genetic engineering for xenotransplantation.

Sandrin MS, Loveland BE, McKenzie IF.

J Card Surg. 2001 Nov-Dec;16(6):448-57. Review.

PMID:
11925025
30.

Role of the mannose receptor in the immune response.

Apostolopoulos V, McKenzie IF.

Curr Mol Med. 2001 Sep;1(4):469-74. Review.

PMID:
11899091
31.

Highlights of the 6th Congress of the International Xenotransplantation Association, Chicago, 2001.

Breimer ME, Cooper DK, d'Apice AJ, Dorling A, McKenzie IF, O'Connell PJ, Shirakura R.

Xenotransplantation. 2002 Mar;9(2):81-90. No abstract available.

PMID:
11897000
32.

Development of a fecal occult blood test using a monoclonal antibody to haptoglobin.

Xing PX, Young G, McKenzie IF.

Redox Rep. 2001;6(6):363-5.

PMID:
11865976
33.

George D. Snell.

McKenzie IF.

Proc Am Philos Soc. 2001 Sep;145(3):369-72. No abstract available.

PMID:
11858279
34.

The cytoplasmic tail of alpha 1,3-galactosyltransferase inhibits Golgi localization of the full-length enzyme.

Milland J, Russell SM, Dodson HC, McKenzie IF, Sandrin MS.

J Biol Chem. 2002 Mar 22;277(12):10374-8. Epub 2002 Jan 2.

35.

LFA-1 and ICAM-1 antibody-idarubicin conjugates separately prolong murine cardiac allograft survival.

Pietersz GA, Sandrin MS, Ling S, Li YQ, McKenzie IFC.

Transpl Immunol. 2001 Oct;9(1):7-11.

PMID:
11680574
36.

Tolerance in baboon kidney transplantation with total lymphoid irradiation (TLI) and anti-CD3/CD4-idarubicin conjugates.

Myburgh JA, Smit JA, Pieterz GA, Ling S, Sandrin MS, McKenzie IF.

Transplantation. 2001 Sep 27;72(6):1150-2.

PMID:
11579315
37.

Anti-mucin monoclonal antibodies.

Xing PX, Apostolopoulos V, Pietersz G, McKenzie IF.

Front Biosci. 2001 Oct 1;6:D1284-95. Review.

PMID:
11578979
38.

Getting into the groove: unusual features of peptide binding to MHC class I molecules and implications in vaccine design.

Apostolopoulos V, McKenzie IF, Wilson IA.

Front Biosci. 2001 Oct 1;6:D1311-20. Review.

PMID:
11578952
39.

Characteristics of immunoglobulin gene usage of the xenoantibody binding to gal-alpha(1,3)gal target antigens in the gal knockout mouse.

Nozawa S, Xing PX, Wu GD, Gochi E, Kearns-Jonker M, Swensson J, Starnes VA, Sandrin MS, McKenzie IF, Cramer DV.

Transplantation. 2001 Jul 15;72(1):147-55.

PMID:
11468550
40.

Mannan Mucin-1 Peptide Immunization: Influence of Cyclophosphamide and the Route of Injection.

Karanikas V, Thynne G, Mitchell P, Ong CS, Gunawardana D, Blum R, Pearson J, Lodding J, Pietersz G, Broadbent R, Tait B, McKenzie IF.

J Immunother (1991). 2001 Mar;24(2):172-183.

PMID:
11449074
41.

The cytoplasmic tail of alpha 1,2-fucosyltransferase contains a sequence for golgi localization.

Milland J, Taylor SG, Dodson HC, McKenzie IF, Sandrin MS.

J Biol Chem. 2001 Apr 13;276(15):12012-8. Epub 2001 Jan 12.

42.

Mannan mucin-1 peptide immunization: influence of cyclophosphamide and the route of injection.

Karanikas V, Thynne G, Mitchell P, Ong CS, Gunawardana D, Blum R, Pearson J, Lodding J, Pietersz G, Broadbent R, Tait B, McKenzie IF.

J Immunother. 2001 Mar-Apr;24(2):172-83.

PMID:
11265775
43.

MUC1 and breast cancer.

Apostolopoulos V, Pietersz GA, McKenzie IF.

Curr Opin Mol Ther. 1999 Feb;1(1):98-103. Review.

PMID:
11249691
44.

Structural implications for the design of molecular vaccines.

Apostolopoulos V, Yu M, McKenzie IF, Wilson IA.

Curr Opin Mol Ther. 2000 Feb;2(1):29-36. Review.

PMID:
11249650
45.

Breast cancer in mice: effect of murine MUC-1 immunization on tumor incidence in C3H/HeOuj mice.

Xing PX, Poulos G, McKenzie IF.

J Immunother. 2001 Jan-Feb;24(1):10-8.

PMID:
11211144
46.

This is an addendum to the February 2000 article by Apostolopoulos et al., "Ly6d-L, a Cell Surface Ligand for Mouse Ly6d."

Sandrin MS, Apostolopoulos J, McKenzie IF.

Immunity. 2000 Dec;13(6):853-854. No abstract available.

47.

Prolonged survival of baboon renal allografts using idarubicin-conjugated anti-CD4 monoclonal antibodies.

Botha JF, Tandon V, Linley W, Mall A, Davison G, Shephard E, McKenzie IF, Kahn D.

Transpl Int. 2000;13 Suppl 1:S480-1.

PMID:
11112059
48.

Selection and characterization of MUC1-specific CD8+ T cells from MUC1 transgenic mice immunized with dendritic-carcinoma fusion cells.

Gong J, Apostolopoulos V, Chen D, Chen H, Koido S, Gendler SJ, McKenzie IF, Kufe D.

Immunology. 2000 Nov;101(3):316-24.

49.

Fucosyl transferase (H) transgenic heart transplants to Gal-/- mice.

McKenzie IF, Li YQ, Patton K, Sandrin MS.

Transplantation. 2000 Oct 27;70(8):1205-9.

PMID:
11063342
50.

Human monocytes bind to ligands on porcine endothelium containing the gal alpha (1,3)-Gal antigen.

Kwiatkowski P, Artrip JH, Michler RE, Wang SF, McKenzie IF, Sandrin MS, Itescu S.

Transplant Proc. 2000 Aug;32(5):931. No abstract available.

PMID:
10936279

Supplemental Content

Loading ...
Support Center